Global Markets for Vaccine Technologies

  • Published: July 2013
  • |
  • Report Code: PHM014E

REPORT HIGHLIGHTS

Global revenue for vaccine technologies was nearly $31.8 billion in 2011. This market is expected to increase from $33.6 billion in 2012 to $43.4 billion in 2017 at a compound annual growth rate (CAGR) of 5.3%.

This report provides:

  • An overview of the global market for human and animal (veterinary) vaccines and related vaccine technologies.
  • Analyses of global market trends, with data from 2010, 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
  • Examination of current and future strategies within the human and animal (veterinary) vaccines markets, including attenuated (live) vaccines, inactivated (killed) vaccines, conjugate vaccines, recombinant/recombinant DNA (rDNA) vaccines, subunit vaccines, toxoid vaccines, and combination vaccines.
  • A breakdown of the seven major categories of vaccines broken down by market shares belonging to leading manufacturers and/or suppliers.
  • Discussion of human and animal (veterinary) vaccines as to their prophylactic or therapeutic use, with emphasis in the meningococcal/pneumococcal vaccines, influenza vaccines, pediatric vaccines, adult/adolescent vaccines, and travel vaccines.

SAMPLE FIGURE
GLOBAL SALES OF HUMAN AND ANIMAL VACCINES, 2010-2017
($ MILLIONS)
GLOBAL SALES OF HUMAN AND ANIMAL VACCINES, 2010-2017
To Contact us, click here  help


Source: BCC Research

Download Report Overview

REPORT SCOPE

SCOPE OF THE STUDY

The report studies the various factors impacting the global market for human and animal vaccines. BCC conducted a market evaluation for vaccine types/categories for humans and animals, including their respective regional sales, applications, regulatory aspects, market forecasts, prospects, innovation and challenges, patent analyses, clinical trials, market leaders and market shares of vaccine sales.

The data gathered is for the global markets and statistically validated for the current and forecasted values. Similar techniques were applied for regional data measurements and sales in the respective regions studied. Product details and scientific techniques/platforms are provided based on their commercial and industrial viability.

The emerging markets for orphan drugs include India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand.

ABOUT THE AUTHOR

The study has been carried out by a team of professionals engaged in the biotechnology industry. The project manager of this study is Shalini S. Dewan, who holds a master’s degree in pharmaceutical chemistry and has more than 14 years of industry experience. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC include: Reagents for Chromatography; Spectroscopy: An Enduring Market; Advanced Drug Delivery Systems: Technologies and Global Markets; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry; The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets; Chiral Technology: Global Markets; Autacoids and Related Drugs: Technologies and Global Markets; Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The Global Market; Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs and Devices; and Cancer Therapies: Technologies and Global Markets.

The lead consultant on this project was Ms. Ruma Chakravarty, who holds a master’s degree in biophysics. She has tremendous experience in market research, quality, process improvement and lean and six sigma concepts.


Download Report Overview

REPORT TOC

Pricing on the website is provided for single users and 2-5 users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at (+1)781-489-7301 or send an email to information@bccresearch.com
  Title/Chapter Name Pages Price
Global Markets for Vaccine Technologies 272 $4655
Chapter- 1: INTRODUCTION - Complimentary 4 $0
  Show Details
Chapter- 2: EXECUTIVE SUMMARY 3 $250
  Show Details
Chapter- 3: OVERVIEW 32 $821
  Show Details
Chapter- 4: REGULATORY ASPECTS 11 $282
  Show Details
Chapter- 5: PREVALENCE 6 $154
  Show Details
Chapter- 6: NEW DEVELOPMENTS 11 $282
  Show Details
Chapter- 7: GLOBAL MARKETS FOR HUMAN AND ANIMAL VACCINES 23 $590
  Show Details
Chapter- 8: MARKET ANALYSIS OF HUMAN VACCINES 60 $1540
  Show Details
Chapter- 9: MARKET ANALYSIS OF ANIMAL VACCINES 21 $539
  Show Details
Chapter- 10: PATENT ANALYSIS 37 $950
  Show Details
Chapter- 11: CURRENT SITUATION 18 $462
  Show Details
Chapter- 12: COMPANY PROFILES 44 $1130
  Show Details
Chapter- 13: APPENDIX I 2 $51
  Show Details
 
  List of Tables
  List of Figures
Select License type:

Original Price 6650.00
Offer Price $4655

buy now

Payment options: credit card, PayPal, wire transfer and check.

download report overview
Want to find out more
about this report?
request more info
Get Notified
on all the latest research reports
Subscribe